Ignite Creation Date:
2024-05-05 @ 10:16 PM
Last Modification Date:
2024-10-26 @ 10:16 AM
Study NCT ID:
NCT01077856
Status:
COMPLETED
Last Update Posted:
2022-09-13
First Post:
2010-02-26
Brief Title:
GARDASIL Vaccine Impact in Population Study V501-033
Sponsor:
Organization:
Merck Sharp Dohme LLC
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
Tissue cervical cells
Enrollment Count:
54516
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Ecologic or Community |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 10351 |
Who Masked List: